Emerging Infectious Diseases (Sep 2020)

Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States

  • Roosecelis B. Martines,
  • Jana M. Ritter,
  • Eduard Matkovic,
  • Joy Gary,
  • Brigid C. Bollweg,
  • Hannah Bullock,
  • Cynthia S. Goldsmith,
  • Luciana Silva-Flannery,
  • Josilene N. Seixas,
  • Sarah Reagan-Steiner,
  • Timothy Uyeki,
  • Amy Denison,
  • Julu Bhatnagar,
  • Wun-Ju Shieh,
  • Sherif R. Zaki

DOI
https://doi.org/10.3201/eid2609.202095
Journal volume & issue
Vol. 26, no. 9
pp. 2005 – 2015

Abstract

Read online

An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further understand its pathogenesis and transmission and for public health prevention measures. We report clinicopathologic, immunohistochemical, and electron microscopic findings in tissues from 8 fatal laboratory-confirmed cases of SARS-CoV-2 infection in the United States. All cases except 1 were in residents of long-term care facilities. In these patients, SARS-CoV-2 infected epithelium of the upper and lower airways with diffuse alveolar damage as the predominant pulmonary pathology. SARS-CoV-2 was detectable by immunohistochemistry and electron microscopy in conducting airways, pneumocytes, alveolar macrophages, and a hilar lymph node but was not identified in other extrapulmonary tissues. Respiratory viral co-infections were identified in 3 cases; 3 cases had evidence of bacterial co-infection.

Keywords